U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    ARMS2 age-related maculopathy susceptibility 2 [ Homo sapiens (human) ]

    Gene ID: 387715, updated on 10-Dec-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration.

    Exploring the contribution of ARMS2 and HTRA1 genetic risk factors in age-related macular degeneration.
    Pan Y, Fu Y, Baird PN, Guymer RH, Das T, Iwata T.

    03/21/2024
    Critical Dependence on Area in Relationship between ARMS2/HTRA1 Genotype and Faster Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report Number 33.

    Critical Dependence on Area in Relationship between ARMS2/HTRA1 Genotype and Faster Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report Number 33.
    Agrón E, Domalpally A, Cukras CA, Chew EY, Keenan TDL, Age-Related Eye Disease Study 2 Research Group.,

    02/2/2024
    Associations of ARMS2 and NR3C2 genes polymorphisms with central serous chorioretinopathy in a Greek population.

    Associations of ARMS2 and NR3C2 genes polymorphisms with central serous chorioretinopathy in a Greek population.
    Giannopoulos K, Gazouli M, Chatzistefanou K, Gouliopoulos N, Lavaris A, Bakouli A, Moschos MM.

    08/31/2023
    Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32.

    Reticular Pseudodrusen Status, ARMS2/HTRA1 Genotype, and Geographic Atrophy Enlargement: Age-Related Eye Disease Study 2 Report 32.
    Agrón E, Domalpally A, Cukras CA, Clemons TE, Chen Q, Swaroop A, Lu Z, Chew EY, Keenan TDL, AREDS and AREDS2 Research Groups., Free PMC Article

    04/26/2023
    Disentangling the Impact of Reticular Pseudodrusen Phenotype and the ARMS2/HTRA1 Risk Allele in Geographic Atrophy: The AREDS 2 Study Report 32.

    Disentangling the Impact of Reticular Pseudodrusen Phenotype and the ARMS2/HTRA1 Risk Allele in Geographic Atrophy: The AREDS 2 Study Report 32.
    Huang BB, Fawzi AA.

    04/26/2023
    Role of CFH Y402H and ARMS2 A69S polymorphisms in susceptibility to post rhegmatogenous retinal detachment macular complications.

    Role of CFH Y402H and ARMS2 A69S polymorphisms in susceptibility to post rhegmatogenous retinal detachment macular complications.
    Aydinlou ZH, Vaezi H, Bonyadi M, Rafat A, Jabbarpoor Bonyadi MH, Soheilian M.

    09/17/2022
    The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.

    The Phenotypic Course of Age-Related Macular Degeneration for ARMS2/HTRA1: The EYE-RISK Consortium.
    Thee EF, Colijn JM, Cougnard-Grégoire A, Meester-Smoor MA, Verzijden T, Hoyng CB, Fauser S, Hense HW, Silva R, Creuzot-Garcher C, Ueffing M, Delcourt C, den Hollander AI, Klaver CCW, European Eye Epidemiology Consortium and EYE-RISK Project.

    07/2/2022
    Serum Levels of ARMS2, COL8A1, RAD51B, and VEGF and their Correlations in Age-related Macular Degeneration.

    Serum Levels of ARMS2, COL8A1, RAD51B, and VEGF and their Correlations in Age-related Macular Degeneration.
    Battu P, Sharma K, Rain M, Singh R, Anand A.

    02/26/2022
    Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci.

    Protective chromosome 1q32 haplotypes mitigate risk for age-related macular degeneration associated with the CFH-CFHR5 and ARMS2/HTRA1 loci.
    Pappas CM, Zouache MA, Matthews S, Faust CD, Hageman JL, Williams BL, Richards BT, Hageman GS., Free PMC Article

    02/5/2022
    Meta-Analysis of the Pharmacogenetics of ARMS2 A69S Polymorphism and the Response to Advanced Age-Related Macular Degeneration.

    Meta-Analysis of the Pharmacogenetics of ARMS2 A69S Polymorphism and the Response to Advanced Age-Related Macular Degeneration.
    Zhang J, Liu Z, Hu S, Qi J.

    11/13/2021
    rs10490924 surrounding HTRA1/ARMS2 regulates the susceptibility of age-related macular degeneration.

    rs10490924 surrounding HTRA1/ARMS2 regulates the susceptibility of age-related macular degeneration.
    Tang M, Li A, Wu M, Chen X, Xiong X, Zhou Z, Liu D.

    10/16/2021
    Ongoing controversies and recent insights of the ARMS2-HTRA1 locus in age-related macular degeneration.

    Ongoing controversies and recent insights of the ARMS2-HTRA1 locus in age-related macular degeneration.
    May A, Su F, Dinh B, Ehlen R, Tran C, Adivikolanu H, Shaw PX.

    10/9/2021
    Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients.

    Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients.
    Krytkowska E, Ulanczyk Z, Grabowicz A, Mozolewska-Piotrowska K, Safranow K, Palucha A, Krawczyk M, Sikora P, Matczynska E, Stahl A, Machalinski B, Machalinska A., Free PMC Article

    10/9/2021
    Binding of Gtf2i-beta/delta transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro.

    Binding of Gtf2i-β/δ transcription factors to the ARMS2 gene leads to increased circulating HTRA1 in AMD patients and in vitro.
    Pan Y, Iejima D, Nakayama M, Suga A, Noda T, Kaur I, Das T, Chakrabarti S, Guymer RH, DeAngelis MM, Yamamoto M, Baird PN, Iwata T., Free PMC Article

    09/4/2021
    Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration.

    Association of CRP levels with ARMS2 and CFH variants in age-related macular degeneration.
    Shijo T, Sakurada Y, Fukuda Y, Yoneyama S, Sugiyama A, Matsubara M, Kikushima W, Tanabe N, Parikh R, Kashiwagi K.

    08/7/2021
    Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.

    Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis.
    Díaz-Villamarín X, Blánquez-Martínez D, Pozo-Agundo A, Pérez-Gutiérrez AM, Muñoz-Ávila JI, Antúnez-Rodríguez A, Fernández-Gómez AE, García-Navas P, Martínez-González LJ, Dávila-Fajardo CL., Free PMC Article

    07/31/2021
    GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY.

    GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY.
    Mohabati D, Schellevis RL, van Dijk EHC, Fauser S, den Hollander AI, Hoyng CB, De Jong EK, Yzer S, Boon CJF., Free PMC Article

    07/10/2021
    Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.

    Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.
    Hayashida M, Miki A, Nakai S, Matsumiya W, Imai H, Kusuhara S, Honda S, Nakamura M., Free PMC Article

    07/3/2021
    Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis.

    Association of combined complement factor H Y402H and ARMS2/LOC387715 A69S polymorphisms with age-related macular degeneration: an updated meta-analysis.
    Jabbarpoor Bonyadi MH, Yaseri M, Soheilian M.

    06/26/2021
    An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.

    An association of neovascular age-related macular degeneration with polymorphisms of CFH, ARMS2, HTRA1 and C3 genes in Czech population.
    Matušková V, Zeman T, Ewerlingová L, Hlinomazová Z, Souček J, Vlková E, Goswami N, Balcar VJ, Šerý O.

    06/5/2021
    Distribution of risk alleles in patients with age-related macular degeneration.

    Distribution of risk alleles in patients with age-related macular degeneration.
    Nielsen MK, Subhi Y, Molbech CR, Grønskov K, Sørensen TL.

    10/31/2020
    Predictive Genes for the Prognosis of Central Serous Chorioretinopathy.

    Predictive Genes for the Prognosis of Central Serous Chorioretinopathy.
    Hosoda Y, Yamashiro K, Miyake M, Ooto S, Oishi A, Miyata M, Uji A, Khor CC, Wong TY, Tsujikawa A.

    09/19/2020
    GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.

    GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY.
    Mohabati D, Schellevis RL, van Dijk EHC, Altay L, Fauser S, Hoyng CB, De Jong EK, Boon CJF, Yzer S.

    09/12/2020
    ARMS2/HTRA1 allele rs10490924 TT genotype is significantly associated with risk of wet age-related macular degeneration in the Pakistani population

    Association of rs10490924 in ARMS2/HTRA1 with age-related macular degeneration in the Pakistani population.
    Ayub H, Shafique S, Azam A, Muslim I, Qazi NA, Akhtar F, Khan MA, Ayub A, Bashir S, Bakker B, Ahmed S, Azam M, den Hollander AI, Qamar R.

    06/27/2020
    CFH and ARMS2 risk alleles do not modify the response to the AREDS2 nutrient supplements with respect to the progression to late AMD (geographic atrophy and neovascular age-related macular degeneration).

    No CFH or ARMS2 Interaction with Omega-3 Fatty Acids, Low versus High Zinc, or β-Carotene versus Lutein and Zeaxanthin on Progression of Age-Related Macular Degeneration in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report No. 18.
    van Asten F, Chiu CY, Agrón E, Clemons TE, Ratnapriya R, Swaroop A, Klein ML, Fan R, Chew EY, Age-Related Eye Disease Study 2 Research Group., Free PMC Article

    03/14/2020
    firstprevious page of 9 nextlast